Mayelana-umdlavuza / ukwelashwa / izidakamizwa / i-ovarian

Izidakamizwa zivunyelwe i-Ovarian, Fallopian Tube, noma i-Primary Peritoneal Cancer

Leli khasi libala izidakamizwa zomdlavuza ezivunyelwe yi-Food and Drug Administration (FDA) ye-ovarian, fallopian tube, noma umdlavuza oyinhloko we-peritoneal. Uhlu lufaka amagama ajwayelekile nawomkhiqizo. Leli khasi futhi libala izinhlanganisela zezidakamizwa ezivamile ezisetshenziswe kulezi zinhlobo zomdlavuza. Izidakamizwa ngazinye ezinhlanganisweni zivunyelwe yi-FDA. Kodwa-ke, ukuhlanganiswa kwezidakamizwa uqobo ngokwazo akuvunyelwe, kepha kusetshenziswa kabanzi.

Amagama ezidakamizwa axhumanisa nezifinyezo ze-Cancer Information Information ze-NCI. Kungaba nezidakamizwa ezisetshenziswa ku-ovarian, fallopian tube, noma kumdlavuza oyinhloko we-peritoneal ongabhalisiwe lapha.

Izidakamizwa zivunyelwe i-Ovarian, Fallopian Tube, noma i-Primary Peritoneal Cancer

Isi-Alkeran (Melphalan)

I-Avastin (Bevacizumab)

Bevacizumab

I-Carboplatin

I-Cisplatin

ICyclophosphamide

I-Doxorubicin Hydrochloride

I-Doxil (Doxorubicin Hydrochloride Liposome)

I-Doxorubicin Hydrochloride Liposome

IGemcitabine Hydrochloride

IGemzar (iGemcitabine Hydrochloride)

IHycamtin (iTototecan Hydrochloride)

Isi-Lynparza (Olaparib)

I-Melphalan

I-Niraparib Tosylate Monohydrate

Olaparib

I-Paclitaxel

I-Rubraca (Rucaparib Camsylate)

I-Rucaparib Camsylate

I-Taxol (Paclitaxel)

Thiotepa

I-Topotecan Hydrochloride

I-Zejula (Niraparib Tosylate Monohydrate)

Ukuhlanganiswa Kwezidakamizwa Kusetshenziswa ku-Ovarian, Fallopian Tube, noma ku-Primary Peritoneal Cancer

I-BEP

ICARBOPLATIN-TAXOL

I-GEMCITABINE-CISPLATIN

JEB

PEB

I-VAC

I-VeIP